NanoViricides Inc. (NNVC)

[KMBJN]

Partner funding would be great. Not sure NNVC knows how to design and run a clinical trial. They did seem to do OK in India Phase I trial.

I just saw this proactive interview:

Diwan actually laughs when he is asked when they will go into clinical trials... whatever that means. Says they are ready, and it's all in the regulators' hands.
He seems to say the next step is to ask FDA for a(nother?) pre-IND meeting to clarify what is needed for an IND for NV-387, the almost everything-cide.

I must say though, NNVC seems closer than ever to getting into a real efficacy trial, and now would probably be a good time to throw some speculative money at it if one was so inclined, provided they can get some funding. Many other antiviral (vaccine) stocks up today on bird-flu "scare." If NV-387 actually works well in humans as well as NNVC says it works in their animal models, it could be an enormous blockbuster: small-pox, RSV, flu, and Covid? It's hard to fake the purported pristine lung pathology in their RSV model. I wonder if they ever intend to publish any of their animal model results with NV-387.

Hopefully a potential partner will be enthusiastic about the human phase I safety and efficacy in animal models, and Aagami can help them find a partner in/for India, Japan, or elsewhere/other markets.